Click main image to view in full screen.
Pharma Strategy: Loss of Exclusivity (LOE) (PowerPoint PPT)
PowerPoint (PPT) 25 Slides FlevyPro Document
DESCRIPTION
Expiration of a drug patent means end of the branded drug value and revenue stream for a majority of pharmaceutical firms. This loss of exclusivity (LOE) puts to risk a huge amount of money in global pharmaceutical sales.
LOE certainly brings about a steep decline in a drug sales. A brand's unit share declines to about 16% by the time generics arrive and play in the market for a year. However, this is not a "game over" scenario.
This deck discusses 3 key strategies to preserve value for the brands after patent expiration:
1. Preserve Brand Equity and Patient Loyalty
2. Develop an Over-the-Counter (OTC) Version
3. Launch a Generic Version
No matter which LOE strategy a company selects to maintain product revenue, early action and execution is critical.
LOE is part of the different phases of a product's lifecycle and should be strategically thought out and managed. The presentation also highlights other avenues to tap revenue opportunities besides extending a drug's patent life through reformulations and introducing new indications.
The slide deck also includes some slide templates for you to use in your own business presentations.
The PPT provides a comprehensive guide on managing the critical phase of Loss of Exclusivity (LOE) in the pharmaceutical industry. It emphasizes the importance of early planning and execution to mitigate the impact on revenue streams. The strategies outlined are not just theoretical, but are backed by practical templates and checklists to facilitate implementation.
The presentation also delves into the nuances of brand affinity and market dynamics, offering insights into how these factors influence the choice of LOE strategy. It includes a detailed timeline for planning and executing LOE strategies, ensuring that companies can navigate this challenging phase with precision and foresight. This resource is indispensable for pharmaceutical executives aiming to sustain brand value and revenue post-patent expiry.
Got a question about the product? Email us at flevypro@flevy.com. If you cannot view the preview above this document description, go here to view the large preview instead.
Source: Best Practices in Pharma Industry PowerPoint Slides: Pharma Strategy: Loss of Exclusivity (LOE) PowerPoint (PPT) Presentation, LearnPPT Consulting
Did you need more documents?
Consider a FlevyPro subscription from $39/month. View plans here.
For $14.00 more, you can download this document plus 2 more FlevyPro documents. That's just $13 each.
